Aesica’s business development, sales and marketing, key account and product management teams will report to Mr. Muir, who will be based at the company’s headquarters in Newcastle, UK.
Mr. Muir has 20 years of experience in the pharma industry. Most recently he was responsible for the global provision of contract development and manufacturing services for oral dose forms at Catalent. He has gained significant commercial experience in contract manufacturing roles for large pharmaceutical companies in Europe, the U.S. and Australia, and has led R&D activities and commercial manufacturing operations.
Dr. Hardy said, “Ian brings strong commercial business knowledge and has proven experience of delivering growth and will play a pivotal role in driving further business growth for Aesica across API, formulation development and formulated products.”